For most multigenic disorders, clinical manifestation (penetrance) and presentation (expressivity) are likely to be an outcome of genetic interaction between multiple susceptibility genes. Here, using gene knockouts in mice, we evaluated genetic interaction between loss of Ret and loss of Sema3d, two Hirschsprung disease susceptibility genes. We intercrossed Ret and Sema3d double null heterozygotes to generate mice with the nine possible genotypes and assessed survival by counting various genotypes, myenteric plexus presence by acetylcholinesterase staining and embryonic day 12.5 (E12.5) intestine transcriptome by RNA-sequencing. Survival rates of Ret wild-type, null heterozygote and null homozygote mice at E12.5, birth and weaning were not influenced by the genotypes at Sema3d locus and vice versa. Loss of myenteric plexus was observed only in all Ret null homozygotes, irrespective of the genotypes at Sema3d locus, and Sema3d null heterozygote and homozygote mice had normal intestinal innervation. As compared with wild-type mice intestinal gene expression, loss of Ret in null homozygotes led to differential expression of $300 genes, whereas loss of Sema3d in null homozygotes had no major consequence and there was no evidence supporting major interaction between the two genes influencing intestine transcriptome. Overall, given the null alleles and phenotypic assays used, we did not find evidence for genetic interaction between Ret and Sema3d affecting survival, presence of myenteric plexus or intestine transcriptome.
Introduction
Hirschsprung disease (HSCR: MIM 142623) is the most common developmental defect of the enteric nervous system (ENS), and is characterized by the lack of ganglion cells in the Auerbach's (myenteric) and Meissner's (submucosal) plexuses in the distal rectum and variable lengths along the gastrointestinal (GI) tract (1) . HSCR has an incidence of $15 in 100 000 newborns among European-ancestry individuals and is the most frequent cause of functional bowel obstruction among newborns (2, 3) . Abnormal migration, proliferation, differentiation, survival or colonization by the enteric neural crest cells (ENCCs) during GI tract development is considered to be the primary defect (4) .
Based on the length of the contiguous aganglionic GI tract, the disorder is classified into short-segment HSCR (S-HSCR: aganglionosis limited to the rectosigmoid colon), long-segment HSCR (L-HSCR: aganglionosis extending to the splenic flexure), total colonic aganglionosis (TCA) or total intestinal aganglionosis (aganglionosis extending into the small intestine) (1) .
HSCR displays characteristics of a multifactorial genetic disorder, including high heritability (>80%), high recurrence risk among siblings (4%), non-Mendelian inheritance patterns, significant sex bias in incidence and variation in clinical expression (length of aganglionosis, associated syndromes), incomplete penetrance and variable expressivity (1, 2) . Human genetic studies have identified rare, high-penetrance coding variants in 15 genes that primarily lead to isolated and/or syndromic forms of HSCR (5) (6) (7) (8) (9) (10) (11) (12) . Collectively, these rare coding variants occur in less than 20% of HSCR cases and are most frequently (>80%) observed in RET that encodes a receptor tyrosine kinase (5, 6) . Expression of all known HSCR genes in enteric neuroblasts or mesenchymal cells during ENS development is indicative of their critical roles in ENCC fate determination and consequent proliferation, migration, survival or colonization and differentiation into enteric neurons (4) . However, in the vast majority of the HSCR cases ($80%), which are isolated and non-syndromic, multiple common, low-penetrance non-coding variants at RET (13) (14) (15) , NRG1 (16) (17) (18) and the SEMA3 (12,19) gene cluster have been identified through association studies. While the causal molecular basis of the genetic associations at the NRG1 and SEMA3 loci remain unknown, functional in vitro and in vivo experiments have shown that some of the HSCR associated risk alleles at the RET locus, such as rs2435357T (14, 20, 21) and rs2506030G (21) , lead to partial loss-of-function (hypomorphs) at hindgut-specific RET enhancers that reduce RET expression.
Although several HSCR-associated coding and non-coding variants at multiple genes/loci have been identified, none of them, however, are individually necessary and sufficient to cause clinical disease, suggesting that disease manifestation is the result of the combined effects of mutant alleles at multiple loci, environmental factors and/or stochastic factors, features common to many human diseases. Indeed, we have previously shown that genetic interaction, both in humans and in mice, between mutant alleles of RET and EDNRB can be necessary and sufficient for the manifestation of HSCR (22, 23) . In an Old Order Mennonite kindred, we had identified statistically significant joint transmission of RET and EDNRB alleles in HSCR cases (22) . And, in an oligogenic mutant mouse model, we had observed complete penetrance of the Ednrb s/s genotype (homozygotes for the hypomorphic piebald allele of Ednrb (Ednrb s )) for developing megacolon and aganglionosis in conjunction with Ret kinase-null heterozygotes (Ret tm1Cs/þ ), which is otherwise $10% in the Ret wild-type background (23) .
Other such HSCR genetic interactions have also been detected. First, we and others have shown genetic interaction between the RET and NRG1 polymorphisms in HSCR risk among Asian ancestry subjects (9, 18) . Second, we have demonstrated significant association between HSCR and common variants at the SEMA3 locus, following which, we demonstrated, using morpholinobased gene expression knockdowns in zebrafish, that genetic interaction between loss-of-function of class 3 semaphorins, sema3c or sema3d, and ret led to aganglionosis in the developing zebrafish intestine (12) . Specifically, injection of morpholinos for either sema3c or sema3d alone in zebrafish embryos led to hypoganglionosis but co-injection with a ret morpholino led to complete loss of migrating ENCCs (12) . These findings indicate the presence of genetic, if not biochemical, interactions between apparently independent signaling pathways. In this study, we have examined the nature of this interaction during mouse intestine development. We generated mice by intercrossing Ret and Sema3d double null heterozygotes (Ret tm2.1Hen/þ or Ret
), to assess genetic interaction between Ret and Sema3d null alleles by studying the, (a) survival at embryonic day 12.5, at birth (P0) and at three weeks of age (P21), (b) presence of the myenteric plexus, as evaluated by acetylcholinesterase (AchE) staining, at P0 and at 2 weeks of age (P14) and (c) E12.5 intestine transcriptome profile. We demonstrate that (i) survival rates of Ret ; Sema3d À/À ) has no major impact on the E12.5 intestine transcriptome. Our results fail to detect and support genetic interaction between Ret and Sema3d in murine ENS development and maintenance, at least with the null alleles and the phenotypic assays used, despite replicated associations at the corresponding human loci.
Results
Absence of genetic interaction for survival between Ret and Sema3d null alleles
Mice heterozygous for the Ret cyan fluorescent protein (CFP) knock-in allele, Ret tm2.1Hen (Ret
), a reporter-tagged null allele (24) , were crossed with mice heterozygous for the Sema3d lacZ-tagged null allele (Sema3d 
Loss of Sema3d does not lead to hypoganglionosis or aganglionosis in the ENS
HSCR is usually diagnosed by the absence of ENCC-derived enteric ganglia from the Auerbach's (myenteric) and Meissner's (submucosal) plexuses in the colon wall. Therefore, to assess genetic interactions at this level, we performed acetylcholinesterase (AchE) staining of whole-mount small and large intestines dissected out from P0 and P14 mice generated by intercrossing Ret S1 ). In P0 mice, the normal reticulate plexus of enteric ganglia was present in the small and large intestines of Ret
and Table 2 ). One copy loss of Ret also did not affect intestinal innervation, as reported previously (24) . However, in all Ret CFP/CFP mice assessed (n ¼ 24), the normal reticulate plexus of enteric ganglia was missing in the small and large intestines and was replaced by large AchE-positive hypertrophic nerve fibers, especially in the distal large intestine ( Fig. 1 and Table 2 ; Supplementary Material, Fig. S1 ). Moreover, this Ret loss-offunction effect was independent of their Sema3d genotype (Ret
and
). In P14 mice, the normal reticulate plexus of enteric ganglia was present throughout the intestine in Ret
observed in P0 mice ( Fig. 2 and Table 2 ). Taken together, these 
Sema3d À/À (bottom, right). Normal myenteric plexus (black arrow) was observed in Ret
, Ret CFP/CFP ; Sema3d À/þ and Ret CFP/CFP ; Sema3d À/À mice display an absence of enteric ganglia and presence of acetylcholinesterase-positive hypertrophic nerve fibers (white arrow). 
, and Ret
results show that loss of Sema3d (Sema3d À/À or Sema3d 
Loss of Sema3d has no major impact on embryonic intestine transcriptome
Despite the absence of measureable genetic interaction between Ret and Sema3d null alleles at a gross phenotypic level (survival and presence of enteric ganglia), we evaluated whether such an interaction existed at a molecular level by comparing the E12.5 intestine transcriptomes and assessing differential gene expression. We looked at E12.5 as it represents a mid-point in development of the enteric neurons in the mouse gut, between embryonic days 10.5 and 14.5, where the intestine is undergoing major morphological and transcriptional changes. We performed stranded mRNA-seq in intestinal tissues dissected from three E12.5 males and three E12.5 females with the following genotypes: Ret
Sema3d
À/À and Ret
CFP/CFP
; Sema3d À/À . Paired-end 100 bp sequencing was performed on an Illumina HiSeq 2500 with a desired sequencing depth of $30 million paired-end reads per sample. The sequencing paired-end reads were processed to remove Illumina adapter sequences and low quality bases using Trimmomatic (25). Gene and isoform expression level estimation was performed using RSEM (26) , which included mapping of trimmed paired-end reads to the mouse genome and GENCODE annotated transcripts using STAR aligner (27) . Supplementary Material Table S1 lists the number of read pairs in each sample at each step of RNA-seq analysis. Differential gene expression analyses were performed using DESeq (28) by comparing RSEM-generated gene-level read count data from six mutants (three males and three females) and six wild-type (three males and three females) mice after adjusting for gender effects based on generalized linear models (Supplementary Material, Table S2-S4 and Fig. S2 ). As compared with E12.5 wild-type intestine, 275 protein-coding genes were differentially expressed (DE) (false discovery rate (FDR) <0.01 and jlog 2 fold-changej>1) in E12.5 Ret
showing that loss of Ret leads to a major impact on the E12.5 intestine transcriptome (Supplementary Material, Table S5 ; see Table S6 ).
In addition to these pair-wise comparisons of main effects from Ret and Sema3d loss, we also assessed possible interactions between Ret and Sema3d loss on intestine transcriptome. We regressed gene expression across all samples using generalized linear models implemented within DESeq (28) . Under one model (main effects only), the regression fit was based on Ret and Sema3d locus genotypes and gender (three variables), while under the other model (main effects plus interaction), the regression fit was based on Ret locus genotype, Sema3d locus genotype, Ret-Sema3d interaction and gender (four variables). On a gene-by-gene basis, the two models were compared, and only one gene (Rpl27-ps3) at FDR 1% or 20 genes (Rpl27-ps3, Lyst, Pdia4, Klhl11, Col12a1, Farp2, Zfp398, Vps13c, Birc6, Itgav, Zfp369, Wdfy2, Tuba1c, Plxna4, Itpripl2, Prex2, Samd5, Rpl29, Herc2 and Zfp729a; sorted by descending rank) at FDR5%, had a significantly better fit under the four variable model (main effects plus interaction), providing evidence for possible genetic interaction. It is important to note that none of these 20 genes, except Plxna4 in Ret
Sema3d
À/À E12.5 intestines (Supplementary Material, Table S7 ).
Collectively, these results highlight the absence of widespread genetic interactions between Ret and Sema3d null alleles on the intestine transcriptome.
Discussion
Previous studies from our laboratory prompted this examination of genetic interaction between Ret and Sema3d in mice, based on the following four observations: (1) genome-wide association studies (GWAS) had mapped a novel HSCR susceptibility locus, in addition to the RET locus, to variants within the SEMA3 gene cluster at chromosome 7q21, (2) among the four genes in the cluster, Sema3c and Sema3d were expressed in a subset of developing ENS cells in mice overlapping with Ret, (3) combined knockdown of sema3c or sema3d led to aganglionosis in the ENS of zebrafish embryos and showed gene interactions with ret and (4) rare loss-of-function variants in SEMA3C and SEMA3D are more frequent in HSCR subjects as compared with controls (12) . In this study, null homozygotes at Ret lead to complete lethality within 24 h of birth arising from the lack of enteric neurons in addition to renal agenesis or severe dysgenesis, as previously reported (24, 29) . Although Sema3d null alleles have also been characterized with respect to defects in the patterning of pulmonary veins during embryogenesis, their effect on survival has not been reported (30) . Here we show that Sema3d null homozygotes show no detectable lethality (survival 96.7%) during embryogenesis (E12.5) with decreasing levels of survival post-birth (51.9%) and post-weaning (26.7%). We have not investigated the cause of this lethality but, based on the anomalous pulmonary vein connections reported (30) , speculate that this arises from cardiac defects. The genetic interaction between ret and sema3c/d loss-of-function we previously observed in the zebrafish (12) could be manifested in many ways in mice. We first tested for an effect of compound genotypes at Ret and Sema3d on survival but failed to detect any effect. However, this assessment does not rule out the possibility of a genetic or biochemical interaction between these genes in ENS development and function without differential consequences on survivability.
Our second approach was to use AchE histochemical staining in the mouse intestine to examine the reticulate plexus of enteric ganglia, because such staining is extensively used in HSCR diagnosis (31) and for characterizing mouse models of HSCR (23, 24) . In Ret null homozygote mice, the reticulate plexus of enteric ganglia, observed in wild-type mice, are missing and are replaced by large AchE-positive hypertrophic nerve fibers, as also reported previously (24) . In contrast, similar studies on intestine tissue from Sema3d null homozygote mice, showed the normal pattern indistinguishable from wild-type mice. Although these results indicate that loss of Sema3d has no apparent effect on mouse ENS formation, it is important to note that not all myenteric neurons are acetylcholine positive. Indeed, in the human colon, $50% of myenteric neurons are positive for choline acetyltransferase only, $40% are positive for nitric oxide synthase only, and, $5% each are positive and negative for both enzymes (32) . Similarly, in guinea pig distal colon, a model in which most extensive knowledge of different enteric neuron types has been obtained, $57% of myenteric neurons are positive for choline acetyltransferase (33) . Thus, AchE staining is unlikely to detect all major enteric neuronal subclasses (34) , suggesting that the Sema3d effect, either alone or in conjunction with Ret loss-of-function, needs to be studied by more detailed examination of myenteric neuron subtypes. It is also important to note that we have not evaluated the submucosal plexus in these assays and thus cannot rule out possible lossof-function defects in the submucosal plexus.
As a third approach, we tested for differences in the intestine transcriptome during mouse development (E12.5) in compound Ret and Sema3d null allele genotypes. Our data clearly show that Ret loss-of-function induces significant changes in the intestine transcriptome ($300 genes) but not that by Sema3d loss-of-function (1 gene). Moreover, the genes' with altered expression in Ret ; Sema3d À/À intestine tissues were substantially overlapping and statistical analysis provided little support for Ret-Sema3d interaction. Once again, these negative results need to be interpreted in the light of knowledge that only $5% of all cells in the mouse intestine tissue comprise the ENS and that tissue-level RNA-seq may not be sensitive to uncover the molecular consequences of loss-offunction at cellular level. Such tests will require transcriptome analysis of isolated ENS cells from mice of various genotypes. Also, we have evaluated the effect on intestine transcriptome at only one time-point during embryonic development (E12.5) and it is possible that the loss of Sema3d mediated molecular effects set in later during development and would require such comparisons to be performed at multiple time points during development. In this regard, it is important to note that conditional loss of key molecules such as Ret (24) and Gfra1 (35) at E14.5 in post-migratory enteric neurons has been shown to induce death of enteric neurons in embryonic colon. Other caveats should be noted to account for the mousezebrafish differences we observe. First, the zebrafish data came from morpholino-based somatic knockdown experiments (12) while the mouse data are from germline null alleles. There is now increasing evidence to support true differences between knockdown and targeted mutation phenotypes across many genes in the mouse, zebrafish and other model systems (36) . One of the likely reasons is that gene knockout, but not knockdown, can lead to activation of compensatory genes and pathways, and subsequent phenotype rescue or diminution of effect (36) . Second, it is not surprising to see differences in phenotypes for at least some gene knockouts versus knockdowns between mouse and zebrafish given the $400 million years of evolutionary divergence between the two species (37). We speculate, particularly given the multiple closely related genes encoding class 3 semaphorins at the Sema3 locus that the critical gene(s) affecting ENS development and function may have changed during evolution. Despite our negative data in mice, we believe that the class 3 semaphorins remain attractive candidates for ENS development and HSCR for the following reasons.
The HSCR GWAS signal in the SEMA3 locus is not a false positive signal having been replicated by us (15) and others (Bjarke Feenstra, personal communication). Within the association signal at 7q21.11, there are only two protein-coding genes, SEMA3A and SEMA3D, both of which are expressed in the ENS. Semaphorins are a family of secreted, transmembrane or glycophosphatidylinositol-anchored proteins implicated in diverse biological processes (38) . Since their initial discovery as axon guidance molecules (39), semaphorins have been known to be involved in migration, proliferation and survival of neurons, patterning of vasculature, immune cell regulation and tumor progression (38) . Specifically, SEMA3A has been shown to be involved in development of microvasculature (40), bone development (41), tumor growth and metastasis (42), inflammatory and immune response (42) and hindgut innervation (43) , and SEMA3D has been shown to be involved in cardiovascular development (30) and tumor growth and metastasis (42) . There are two more class 3 semaphorins in this gene cluster, SEMA3C and SEMA3E, but these map outside the association signal, $4Mb and $1.2Mb upstream of the GWAS hit, respectively, and are not likely candidates. The literature suggests that SEMA3A is a promising HSCR candidate. Sema3a has been shown, using Sema3a null mice, to regulate the entry of sacral enteric neural precursors into the distal hindgut in mice by acting as a repulsive signal secreted from the intestine mesenchyme (43) . Increased expression of SEMA3A in aganglionic smooth muscle layer of the colon has also been reported in some HSCR patients (44) . Finally, by targeted sequencing in HSCR subjects, rare coding deleterious variants have been identified in SEMA3C and SEMA3D by us (12) and in SEMA3A and SEMA3D by others (11) . Although in our previous work, we did not detect Sema3a expression in the mouse ENS during development by RNA in situ hybridization and did not observe loss of enteric neurons upon sema3aa/sema3ab knockdown in zebrafish embryos (12), we do detect Sema3a expression in E12.5 intestine by RNA-seq here, which is a higher sensitivity assay.
Based on the physiological roles inferred for class 3 semaphorins from various knockout mice, as outlined above, one could argue that assessing axonal projections of enteric neurons to their targets (circular muscle, longitudinal muscle, mucosa, blood vessels) in knockout/knockdown models would be more appropriate than assessing the myenteric plexus by AchE staining (34) , especially when class 3 semaphorins have been shown to pattern axonal projections in spinal cord by selectively repelling one class of axons but not the others (45) . A more direct approach to identifying the human susceptibility gene within the SEMA3 cluster would be to identify the functional basis of the risk association through identification of the cis regulatory element and the target gene it regulates.
Materials And Methods

Generation of Ret and Sema3d null mice
Mice heterozygous for the Ret CFP knock-in allele, Ret
), a reporter-tagged null allele, were obtained by David Ginty (Johns Hopkins University, Baltimore, MD, USA) from Hideki Enomoto (RIKEN Center for Developmental Biology, Kobe, Japan); their generation has been previously described (24) . Mice heterozygous for the Sema3d lacZ-tagged null allele (Sema3d À/þ ) were generated by David Ginty's laboratory; their generation will be described elsewhere. 
). Timed matings were evaluated by checking females for vaginal plugs and matings were assumed to occur at the midpoint of the dark cycle.
Genotyping
For newborns (P0), 2 weeks (P14) and 3 weeks (P21) old mice, genomic DNA was isolated from tail-tips, and for embryonic day 12.5 (E12.5) mice, genomic DNA was isolated from one hind limb, following standard methods. For the Ret locus, mice were genotyped using two PCRs with the following primers: Ret 
Acetylcholinesterase histochemistry
The acetylcholinesterase (AchE) staining protocol was adapted from published methods (48, 49) . Briefly, P0 and P14 mice were euthanized using inhaled isoflurane in a closed chamber. The entire intestine was dissected out, followed by removal of the mesentery in cold phosphate buffered saline (PBS, ThermoFisher Scientific) under a stereo microscope. Intestine tissue was irrigated with cold PBS to flush out fecal contents using a 30 gauge needle syringe. Tissues were fixed in excess of fresh 4% paraformaldehyde (PFA, Electron Microscopy Sciences) in PBS for 1 h at 4 C and then stored overnight at 4 C in saturated sodium sulfate (24.5 g sodium sulfate in 100 mL water, Sigma). Tissues were then incubated in substrate buffer, pH 5.5 (Ethopropazine HCl 0.2 mM, Acetylthiocholine iodide 4 mM, glycine 10 mM, cupric sulfate pentahydrate 2 mM, sodium acetate 65 mM in water, Sigma) at room temperature with gentle rocking for 2 h (P14) or 4 h (P0). AchE staining was developed by incubating tissues in 1.25% sodium sulfide, pH 6.0, (1.25 g sodium sulfide non-ahydrate in water, Sigma), at room temperature with gentle rocking for 2 min (P14) or 6 min (P0). Tissues were then rinsed in excess water at room temperature with gentle rocking for 6 Â 5 min. Stained tissues were photographed (transillumination for P0 and epi-illumination for P14) as whole mounts in water using a stereo microscope.
RNA isolation, library preparation and sequencing RNA-seq was performed from E12.5 intestine tissue from three males and three females from the following genotypes: Ret
. Total RNA was isolated from each E12.5 intestine using RNeasy Mini Kit following manufacturers' recommendations (Qiagen) that included the on-column DNase digestion using RNase-Free DNase set (Qiagen). The quantity and quality of total RNA was assessed by NanoDrop spectrophotometer (Thermo Scientific). KAPA Stranded mRNA-Seq kit (KAPA Biosystems) was used to generate indexed Illumina platform sequencing libraries. Briefly, polyA RNA was captured from 1 mg total RNA using magnetic oligo-dT beads. After elution from the magnetic beads, polyA RNA was fragmented to generate inserts ranging in size from 100 to 200 bp, followed by random priming and reverse transcription to generate double-stranded cDNA. Next, after performing a 1.8Â SPRI cleanup using AMPure XP beads (Agencourt), dAMP was added to 3 0 ends of the cDNA fragments followed by ligation with indexed 3 0 dTMP Illumina TruSeq adapters. Ligated fragments were subsequently size selected using PEG/NaCl SPRI solution and underwent PCR amplification (12 cycles) to generate the sequencing libraries. After performing a 1Â SPRI cleanup using AMPure XP beads (Agencourt), a sample from each library was used to assess library fragment size distribution by electrophoresis using BioAnalyzer High Sensitivity DNA Assay (Agilent Technologies) and to assess library concentration by qPCR using KAPA library quantification kit (KAPA Biosystems). Equimolar amounts of libraries were pooled and sequenced on an Illumina HiSeq 2500 instrument using standard protocols for paired-end 100 bp sequencing with a desired sequencing depth of $30 million paired end reads per library.
RNA-seq analyses
Illumina RNA-seq paired-end read fastq files were quality checked using FASTQC (version: 0.11. (27) indices using the RSEM software package (version: 1.2.31) (26) . Trimmed paired-end reads from each sample were then aligned to the reference transcript sequences by calling the STAR aligner within RSEM and using alignment parameters from the ENCODE STAR-RSEM long RNAseq pipeline (-outSAMunmapped Within -outFilterType BySJout -outSAMattributes NH HI AS NM MD -outFilterMultimapNmax 20 -outFilterMismatchNmax 999 -outFilterMismatchNoverLmax 0.04 -alignIntronMin 20 -alignIntronMax 1 000 000 -alignMates GapMax 1 000 000 -alignSJoverhangMin 8 -alignSJDBover hangMin 1 -sjdbScore 1 -quantMode TranscriptomeSAM). Gene and isoform expression levels were then estimated in each sample from these transcriptome alignments using RSEM keeping in mind the strandedness of the prepared RNA-seq libraries (-forward-prob 0.0). Gene-level read count data generated by RSEM was compared between various wild-type and mutant mice to assess differential gene expression using the DESeq software (version: 1.24.0) (28) . Only those genes where the sum of read counts across the 12 samples in each comparison (three male and three female wild-type and the three male and three female mutant replicates) was >1, were retained for differential gene expression analysis. Although, release M10 of the GENCODE primary assembly gene annotation has 48 526 genes, we limited differential gene expression comparison to only protein coding genes (22 098) and calculated false-discovery rates (FDR) based on the number of protein coding genes within each comparison. FDR were calculated from P-values using the BenjaminiHochberg procedure (50) . All data have been deposited in NCBI's GEO and are accessible at GEO Series accession number GSE89627.
Pathway enrichment analysis
Pathway over-representation or enrichment analysis was performed for the set of differentially expressed genes using the online ConsensusPathDB tool (51) (http://cpdb.molgen.mpg.de/; date last accessed January 10, 2016). Among all the available pathway databases, the enrichment analysis was limited to KEGG (52) database and was restricted to report only those pathways with a minimum overlap of two genes among the differentially expressed genes and a P-value <0.01.
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